Abiopharma

New Form 6-K - Haleon plc Filed: 2025-08-12 AccNo: 0001654954-25-009386 Size: 83 KB

New Form 8-K - RAPID MICRO BIOSYSTEMS, INC. Filed: 2025-08-12 AccNo: 0001380106-25-000169 Size: 299 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant …

DarioHealth Reports Second Quarter 2025 Financial and Operating Results

New Form 8-K - Liquidia Corp Filed: 2025-08-12 AccNo: 0001104659-25-076412 Size: 256 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results

Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress

Zomedicas Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.

DarioHealth Reports Second Quarter 2025 Financial and Operating Results

New Form 6-K - Haleon plc Filed: 2025-08-12 AccNo: 0001654954-25-009378 Size: 40 KB

New Form SCHEDULE 13G/A - ARGENX SE Filed: 2025-08-12 AccNo: 0001193125-25-178428 Size: 141 KB

New Form SCHEDULE 13G/A - Twist Bioscience Corp Filed: 2025-08-12 AccNo: 0001193125-25-178424 Size: 141 KB

New Form 8-K - Amphastar Pharmaceuticals, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011134 Size: 195 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - GSK plc Filed: 2025-08-12 AccNo: 0001654954-25-009371 Size: 5 MB